Baidu
map

肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

Gitelman 综合征诊疗中国专家共识（2021版）

2021-11-30 中国研究型医院学会 协和医学杂志

Gitelman综合征染色体隐性遗传病

基于最新循证医学证据，多学科领域专家在Gitelman综合征的临床表型、诊断、治疗、慢性并发症及合并症管理方面达成一致共识，为临床规范化诊疗提供了重要依据。

中文标题：

Gitelman 综合征诊疗中国专家共识（2021版）

发布机构：

中国研究型医院学会

发布日期：

2021-11-30

简要介绍：

近年来，国内对Gitelman综合征的研究取得了长足进步，中国人群Gitelman综合征新的临床表型、疾病分型、改良功能试验、生物标志物和特殊人群管理经验相继在国内外期刊报道。基于最新循证医学证据，多学科领域专家在Gitelman综合征的临床表型、诊断、治疗、慢性并发症及合并症管理方面达成一致共识，为临床规范化诊疗提供了重要依据。

评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1198712, encodeId=3bf91198e12c7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4276529724, createdName=ms5000000419107400, createdTime=Wed Mar 02 14:36:39 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188343, encodeId=5b8c118834331, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=767b1596691, createdName=susan0126, createdTime=Wed Jan 26 17:23:53 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185784, encodeId=6aa11185e849e, content=嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0411309316, createdName=白丽萍, createdTime=Tue Jan 18 21:47:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083342, encodeId=1f0a108334293, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:12 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083341, encodeId=b2bf10833413a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:11 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-03-02 ms5000000419107400

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1198712, encodeId=3bf91198e12c7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4276529724, createdName=ms5000000419107400, createdTime=Wed Mar 02 14:36:39 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188343, encodeId=5b8c118834331, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=767b1596691, createdName=susan0126, createdTime=Wed Jan 26 17:23:53 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185784, encodeId=6aa11185e849e, content=嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0411309316, createdName=白丽萍, createdTime=Tue Jan 18 21:47:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083342, encodeId=1f0a108334293, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:12 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083341, encodeId=b2bf10833413a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:11 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-01-26 susan0126

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1198712, encodeId=3bf91198e12c7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4276529724, createdName=ms5000000419107400, createdTime=Wed Mar 02 14:36:39 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188343, encodeId=5b8c118834331, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=767b1596691, createdName=susan0126, createdTime=Wed Jan 26 17:23:53 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185784, encodeId=6aa11185e849e, content=嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0411309316, createdName=白丽萍, createdTime=Tue Jan 18 21:47:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083342, encodeId=1f0a108334293, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:12 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083341, encodeId=b2bf10833413a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:11 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-01-18 白丽萍

    嗯

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1198712, encodeId=3bf91198e12c7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4276529724, createdName=ms5000000419107400, createdTime=Wed Mar 02 14:36:39 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188343, encodeId=5b8c118834331, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=767b1596691, createdName=susan0126, createdTime=Wed Jan 26 17:23:53 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185784, encodeId=6aa11185e849e, content=嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0411309316, createdName=白丽萍, createdTime=Tue Jan 18 21:47:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083342, encodeId=1f0a108334293, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:12 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083341, encodeId=b2bf10833413a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:11 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1198712, encodeId=3bf91198e12c7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4276529724, createdName=ms5000000419107400, createdTime=Wed Mar 02 14:36:39 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188343, encodeId=5b8c118834331, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=767b1596691, createdName=susan0126, createdTime=Wed Jan 26 17:23:53 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185784, encodeId=6aa11185e849e, content=嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0411309316, createdName=白丽萍, createdTime=Tue Jan 18 21:47:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083342, encodeId=1f0a108334293, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:12 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083341, encodeId=b2bf10833413a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:11 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

Gitelman综合征诊治专家共识

肾脏病相关专家小组（统称） · 2017-09-28

拓展阅读

Gitelman综合征诊治专家共识

肾脏病相关专家小组（统称） · 2017-09-28

Baidu
map
Baidu
map
Baidu
map